Figure 2.

Effect of cycloheximide (fig 2A, 10 μg/ml for 2 h) and actinomycin D (Fig 2B, 10 μg/ml for 2 h) on mICAM-1 surface expression in IFN-γ treated uninfected and HRV-14 infected cells. Data are mean ± S.E. of three separate experiments (Fig. 2A, *p < 0.05, cycloheximide treated cells compared with equivalent un-treated cells, **p < 0.05, IFN-γ treated uninfected cells compared with IFN-γ treated infected cells, Fig. 2B, *p < 0.05, actinomycin D treated cells compared with equivalent untreated cells).